Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Plos One|August 30, 2018
Hierarchical communities in the walnut structure of the Japanese production networkAbhijit Chakraborty, Yuichi Kichikawa, Takashi Iino, et al.
Plos One|May 2, 2015
Bank-firm credit network in Japan: an analysis of a bipartite networkLuca Marotta, Salvatore Miccichè, Yoshi Fujiwara, et al.
Human Pathology|March 15, 2008
Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis?Suzuko Moritani, Shu Ichihara, Masaki Hasegawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 30, 2002
[CGS 20267 (Letrozole), a new aromatase inhibitor: early phase II study for postmenopausal women with advanced breast cancer]Yasuo Nomura, Takeshi Tominaga, Kouji Enomoto, et al.
Breast Cancer (Tokyo, Japan)|November 20, 2004
A phase II study of S-1 in patients with metastatic breast cancer--a Japanese trial by the S-1 Cooperative Study Group, Breast Cancer Working GroupToshiaki Saek, Shigemitsu Takashima, Muneaki Sano, et al.
Histopathology|March 16, 2011
Topographical, morphological and immunohistochemical characteristics of carcinoma in situ of the breast involving sclerosing adenosis. Two distinct topographical patterns and histological types of carcinoma in situSuzuko Moritani, Shu Ichihara, Masaki Hasegawa, et al.
Anticancer Research|July 28, 2004
Combination chemotherapy with docetaxel and doxifluridine showed a beneficial outcome in advanced or recurrent breast cancer patients with longer disease-free intervalReiki Nishimura, Takeshi Tominaga, Shoshu Mitsuyama, et al.
Oncology Reports|September 18, 2004
1-hexylcarbamoyl-5-fluorouracil + cyclophosphamide + tamoxifen versus CMF + tamoxifen in women with lymph node-positive breast cancer after primary surgery: a randomized controlled trialTakeshi Tominaga, Morihiko Kimura, Taro Asaga, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 31, 2002
[Early phase II dose-finding study of exemestane in postmenopausal patients with advanced/recurrent breast cancer]Toshio Tabei, Masami Ogita, Kouichi Hirata, et al.
Pageof 2